Today, the US FDA approved Erleada (apalutamide), an androgen receptor inhibitor created by Janssen Pharmaceuticals for the treatment of men with non-metastatic, castration-resistant prostate cancer. Erleada was approved after a priority review of...

Dr. Steven Gange graduated from the UCLA School of Medicine in 1986. After his Urology residency training at the University of Kentucky in 1991, he entered the US Army as an academic urologist, teaching and training residents. He joined Western Urological Clinic (now Summit Urology Group) in Salt Lake City, UT, in 1996. With over 25 years of clinical and research experience, he has developed a particular expertise in men’s health urology.

This is my third and final post on whole foods, plant-based eating/nutrition – read my previous two posts here and here. This post was inspired by Admiral William McRaven’s commencement address at the U. of Texas, Austin; often called the “Make Your Bed Speech”. Admiral McRaven, a former Navy Seal, outlines...

Last post I wrote about a whole foods, plant-based diet as an eating strategy which is perhaps better than exercise for its positive health benefits.  Because people’s needs differ in terms of the type of information/support needed to implement a plant-based eating strategy...

Proton beam therapy, a form of external beam radiation, has been around for a while but is less commonly utilized than other forms of radiation therapy, which is partly due to availability. Certain properties of protons show potential for a different approach to radiation therapy. This article also considers how implementation of imaging helps improve treatment outcomes. 

Jonathan was diagnosed in 2009 with intermediate risk prostate cancer, at age 63.  He underwent two years of androgen deprivation therapy (hormonal therapy), and radiation treatment.  After a few years off treatment, he developed metastatic recurrence in 2014, but continues to do very well with his current regimen. 

Hello Researcher, welcome to a new issue of Prostate Insights, a newsletter that brings you the latest information about prostate cancer. In addition to arresting the progress of cancer growth, it is of equal if not--in some cases--of more importance to focus on quality of life issues that arise as a result of one's treatment choice.

Uncontrolled cancer cell growth results from misbehaving genes. An intriguing approach to cancer therapy is to identify the mutated genes and target treatment to specifically counteract the damaging  effects of that gene...

The 2017 Prostate Cancer Patient Conference was yet another incredible conference with presentations from some of the best medical professionals. The conference featured topics covering active surveillance, radiation therapy, sexual and urinary dysfunction...

SpaceOAR is a new rectal protection product for men with prostate cancer undergoing radiation therapy. SpaceOAR reduces the risk of rectal toxicity, also known as radiation enteropathy, a potential side effect of radiation that can be permanent after radiation..